Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions
- PMID: 2991961
- DOI: 10.1007/BF00429666
Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions
Abstract
The open-field test was used to study the involvement of serotonergic and dopaminergic mechanisms in the action of lisuride on locomotor activity in the rat. Lisuride produced a biphasic locomotor effect. The maximum locomotor stimulatory response of lisuride was stronger than that of apomorphine and comparable with that of apomorphine and LSD combined. Hypermotility induced by high doses of lisuride was partially suppressed by the serotonin antagonist cyproheptadine and not further enhanced by LSD. A moderate dose of lisuride potentiated apomorphine-induced hypermotility in the same manner as has been shown for LSD. Lesion of dopaminergic structures within the median raphe nucleus by 6-OHDA produced a potentiation of lisuride-induced hypermotility. This effect was suppressed by cyproheptadine. The locomotor inhibitory effect of low doses of lisuride may be related to a stimulation of presynaptic mesolimbic dopamine receptors. It is concluded that the locomotor stimulant effect of higher doses of lisuride may depend on stimulation of postsynaptic dopamine receptors and a serotonergic action and that the locomotor effects of lisuride reflect a complex interaction at dopaminergic and serotonergic transmission systems.
Similar articles
-
Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".Psychopharmacology (Berl). 1979 Nov;65(3):233-7. doi: 10.1007/BF00492209. Psychopharmacology (Berl). 1979. PMID: 117494 No abstract available.
-
Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.Acta Biol Med Ger. 1980;39(8-9):903-10. Acta Biol Med Ger. 1980. PMID: 7282220
-
2-Bromolisuride, an ergot derivative, with dopamine antagonistic and serotonin agonistic properties.Pharmacol Biochem Behav. 1991 Feb;38(2):321-5. doi: 10.1016/0091-3057(91)90285-a. Pharmacol Biochem Behav. 1991. PMID: 1905409
-
The involvement of serotonin in the mechanism of central action of apomorphine.Pol J Pharmacol Pharm. 1976 May-Jun;28(4):389-94. Pol J Pharmacol Pharm. 1976. PMID: 790347 Review.
-
LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev. 2004 Jan;27(8):693-701. doi: 10.1016/j.neubiorev.2003.11.012. Neurosci Biobehav Rev. 2004. PMID: 15019419 Review.
Cited by
-
The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice.Front Mol Biosci. 2023 Oct 10;10:1233743. doi: 10.3389/fmolb.2023.1233743. eCollection 2023. Front Mol Biosci. 2023. PMID: 37900918 Free PMC article.
-
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited.ACS Pharmacol Transl Sci. 2024 Feb 5;7(3):641-653. doi: 10.1021/acsptsci.3c00192. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481684 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources